Attentive Science at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Attentive Science takes part in 1 session at ACT 2026 in San Antonio, and exhibits at Booth 211. Its program centres on in vivo gene therapy, with mechanism-driven strategies that help safety findings from nonclinical studies carry over to patients.

OrganizationACT 2026 Attendance
Attentive Science
Stillwell, KS
attentivescience.com
Contract research organizations (CROs)
Contract research organization in Kansas offering pharmacokinetics, discovery toxicology through IND-enabling studies, and safety pharmacology.
Booth
Exhibiting at Booth 211
Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm
Talk
Mon Nov 16
2:40pm–3:15pm
Part of In Vivo Gene Therapies: Breakthrough Innovations, Regulatory Roadmaps, and Development Challenges (S04)
Mechanism-Driven Strategies for Translational Safety Success in Gene Therapy (S04-3)
Biologics and new modalities · Translational safety

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Attentive Science

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction